7.7 USD
+0.26 (+3.49%)
7.6659 USD
-0.03 (-0.44%)
ChartMill assigns a Buy % Consensus number of 80% to VNDA. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 11.99. This target is 55.65% above the current price.
- VNDA was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about VNDA.
- In the previous month the buy percentage consensus was at a similar level.
- VNDA was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-12-31 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-12-31 | Jefferies | Maintains | Hold -> Hold |
| 2025-11-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-11-05 | B. Riley Securities | Initiate | Buy |
| 2025-10-30 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-08-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Initiate | Buy |
| 2024-08-01 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-07-11 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-02-25 | Jefferies | Downgrade | Buy -> Hold |
| 2021-05-12 | B of A Securities | Initiate | Buy |
VANDA PHARMACEUTICALS INC / VNDA FAQ
What is the average price target for VANDA PHARMACEUTICALS INC (VNDA) stock?
10 analysts have analysed VNDA and the average price target is 11.99 USD. This implies a price increase of 55.65% is expected in the next year compared to the current price of 7.7.
What is the consensus rating for VNDA stock?
The consensus rating for VANDA PHARMACEUTICALS INC (VNDA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for VANDA PHARMACEUTICALS INC stock?
The number of analysts covering VANDA PHARMACEUTICALS INC (VNDA) is 10.